Ampio Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Ampio Pharmaceuticals Inc.
Vanguard Total Stock Market Index Fund
1,941,946
1.82%
0
0%
07/31/2018
iShares Russell 2000 ETF
1,659,685
1.56%
-885
0%
09/06/2018
Vanguard Extended Market Index Fund
979,690
0.92%
14,222
0%
07/31/2018
iShares Russell 2000 Growth ETF
919,551
0.86%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
318,736
0.3%
0
0%
07/31/2018
iShares Micro Cap ETF
214,266
0.2%
0
0.01%
09/06/2018
Fidelity Spartan Total Market Index Fund
168,674
0.16%
0
0%
07/31/2018
Schwab Small Cap Index Fund
147,900
0.14%
147,900
0%
06/30/2018
140,420
0.13%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
137,683
0.13%
0
0%
09/06/2018
| Address |
373 Inverness Parkway
Englewood Colorado 80112
United States
|
|
Employees
|
- |
| Website |
http://www.ampiopharma.com |
| Updated |
07/08/2019 |
| Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO. |
